HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trofopar treatment of chronic liver diseases.

Abstract
The clinical study on the Romanian product Trofopar was performed on 71 patients affected by chronic liver diseases; of them 30 patients suffered from cirrhosis decompensated at the parenchymal and vascular level. The clinical results corroborated with laboratory tests substantiate the efficacy of Trofopar, which improves liver blood circulation, increases the capacity of hepatocyte regeneration, detoxification and metabolization.
AuthorsA S Loghinov, G V Suhareva, E A Bendikov, I E Blok, C J Astasenkova, A P Nicolaeva
JournalRomanian journal of internal medicine = Revue roumaine de medecine interne (Rom J Intern Med) 1991 Jan-Jun Vol. 29 Issue 1-2 Pg. 65-74 ISSN: 1220-4749 [Print] Germany
PMID1947713 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Peptides
  • trofopar
  • Leucine
  • Antipyrine
Topics
  • Adolescent
  • Adult
  • Aged
  • Antipyrine
  • Chronic Disease
  • Female
  • Hepatitis, Chronic (blood, drug therapy)
  • Humans
  • Leucine (blood, drug effects)
  • Liver Cirrhosis (blood, drug therapy)
  • Liver Diseases (blood, drug therapy)
  • Male
  • Middle Aged
  • Peptides (therapeutic use)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: